Asymmetry Capital Management, L.P. 13F Holdings · last filed Q4 2021
Asymmetry Capital Management, L.P. reported 24 securities worth $188.38M in its SEC 13F filing for Q4 2021 (period ended 2021-12-31). Top holdings: BMRN (8.34%), HZNP (7.87%), UNH (7.16%). Among its top 25 positions this quarter: 9 new, 8 added, 7 trimmed, 1 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | BMRN | BIOMARIN PHARMACEUTICAL INC | $15.7M | 8.34% | 177,741 | New |
| 2 | HZNP | HORIZON THERAPEUTICS PLC | $14.8M | 7.87% | 137,610 | Added |
| 3 | UNH | UNITEDHEALTH GROUP INC | $13.5M | 7.16% | 26,844 | New |
| 4 | ABBV | ABBVIE INC | $12.8M | 6.79% | 94,448 | New |
| 5 | IQV | IQVIA HOLDINGS INC | $12.5M | 6.64% | 44,314 | New |
| 6 | CNC | CENTENE CORP | $12.2M | 6.48% | 148,254 | New |
| 7 | BLU | BELLUS HEALTH INC | $10.3M | 5.47% | 1.3M | Added |
| 8 | CYTK | CYTOKINETICS INC | $10.3M | 5.44% | 225,032 | Trimmed |
| 9 | JNJ | JOHNSON & JOHNSON | $9.5M | 5.06% | 55,755 | New |
| 10 | NTRA | NATERA INC | $9.5M | 5.04% | 101,674 | New |
| 11 | FOLD | AMICUS THERAPEUTICS INC | $8.3M | 4.39% | 716,709 | Added |
| 12 | ARGX | ARGENX SE - ADR | $7.3M | 3.88% | 20,881 | New |
| 13 | KURA | KURA ONCOLOGY INC | $7.0M | 3.73% | 502,275 | Added |
| 14 | APLS | APELLIS PHARMACEUTICALS INC | $6.6M | 3.50% | 139,445 | New |
| 15 | MRTX | MIRATI THERAPEUTICS INC | $6.4M | 3.42% | 43,876 | Added |
| 16 | ISEE | IVERIC BIO INC | $6.3M | 3.34% | 375,989 | Added |
| 17 | QTRX | QUANTERIX CORP | $6.1M | 3.22% | 143,204 | Trimmed |
| 18 | ITOS | ITEOS THERAPEUTICS INC | $4.9M | 2.59% | 104,755 | Added |
| 19 | DICE | DICE MOLECULES HOLDINGS ORD | $4.7M | 2.49% | 185,201 | Trimmed |
| 20 | AVDL | AVADEL PHARMACEUTICALS PLC | $3.0M | 1.58% | 369,134 | Trimmed |
| 21 | ACRS | ACLARIS THERAPEUTICS INC | $2.9M | 1.53% | 198,493 | Trimmed |
| 22 | PMVP | PMV PHARMACEUTICALS INC | $2.3M | 1.20% | 97,680 | Trimmed |
| 23 | RGLS | REGULUS THERAPEUTICS INC | $860,000 | 0.46% | 2.7M | Added |
| 24 | BLSA | BCLS ACQUISITION CORP- CL A | $699,000 | 0.37% | 71,372 | Trimmed |
| 25 | ALKS | ALKERMES PLC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2021-12-31
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR